Treating Kaposi sarcoma in people living with HIV
Project 2
This project looks at how immune recovery, antiretroviral therapy, and chemotherapy help people with HIV who have Kaposi sarcoma.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Lsu Health Sciences Center NIH-funded |
| Lab location | 1 site (New Orleans, United States) |
| Project ID | NIH-11184259 on NIH RePORTER |
What this research studies
You would be part of work focused on HIV-associated Kaposi sarcoma, using the ACTG staging system to describe tumor extent, immune status, and systemic illness. Doctors will follow people on antiretroviral therapy alone or antiretroviral therapy plus chemotherapy and monitor clinical outcomes over time. The project also measures T cell immune responses and virus markers to understand why some people improve while others do not. Care and laboratory testing happen at participating clinical sites to track treatment response and disease progression.
Who could benefit from this research
Good fit: Ideal candidates are people living with HIV who have newly diagnosed or active Kaposi sarcoma and are receiving or about to start HIV treatment at a participating site.
Not a fit: People who do not have Kaposi sarcoma, do not have HIV, or whose health prevents them from receiving ART or chemotherapy are unlikely to benefit directly from this project.
Why it matters
Potential benefit: If successful, this work could help clinicians choose treatments that lead to better tumor control and fewer complications for people with HIV-associated Kaposi sarcoma.
How similar studies have performed: Previous research shows that antiretroviral therapy can shrink early Kaposi sarcoma and chemotherapy helps advanced cases, but responses vary and the immune mechanisms remain incompletely understood.
Where this research is happening
New Orleans, United States
- Lsu Health Sciences Center — New Orleans, United States (Active)
Researchers
- Principal investigator: West, John T. — Lsu Health Sciences Center
- Study coordinator: West, John T.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.